Background and aims. In Europe a wide variation in HCV prevalence between countries was described, ranging from 0.1 to 6.0%, higher in Eastern Europe than in Western Europe, which may threaten the biological safety of donated blood. The HCV frequency among blood donors in Romania has has made the object of only very few published studies. The aim of this study was to analyze the frequency of anti-HCV antibodies in blood donors from Cluj County (Romania) and its trend, in the period 2006-2011. Patients and methods. Between 2006-2011 all donors, new and repeat donors were screened for hepatitis C virus infections using enzyme-linked immunosorbent assay (ELISA). Reactive results were confirmed using radioimmunoblotting assay (RIBA). The freque...
In 2022, the Lithuanian health authorities decided to pay general practitioners a fee for performing...
It is estimated that approximately 130-170 million people worldwide are infected with hepatitis C vi...
Given the scarcity of epidemiological information on hepatitis C virus (HCV) infection in Northern B...
The anti-HCV antibody (C100-3) is present in the serum of 70-90% of patients that are carriers of po...
BackgroundWe evaluate the current prevalence of serologic markers for hepatitis B virus (HBV) and he...
Objective: Screening blood donors for sexually transmitted diseases is becoming increasingly importa...
Abstract Hepatitis is disease of the liver caused by the infectious and non-infectious agents. The a...
Abstract. The prevalence of HCV seropositivity observed in various populations raise the issue of th...
IntroductionEstimation of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficienc...
A second generation test for HCV antibody detection in sera coming from Stip county is used. The per...
Latest estimates indicate that world prevalence of anti-HCV reactivity spans widely from 0.1% in dev...
Introduction Estimation of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficien...
Hepatitis is disease of the liver caused by the infectious and non-infectious agents. The aim of stu...
BACKGROUND: The epidemiology of hepatitis C virus (HCV) infection has been studied in many countries...
Background: In Brazil, it is estimated that between 2.5 and 4.9% of the general population present a...
In 2022, the Lithuanian health authorities decided to pay general practitioners a fee for performing...
It is estimated that approximately 130-170 million people worldwide are infected with hepatitis C vi...
Given the scarcity of epidemiological information on hepatitis C virus (HCV) infection in Northern B...
The anti-HCV antibody (C100-3) is present in the serum of 70-90% of patients that are carriers of po...
BackgroundWe evaluate the current prevalence of serologic markers for hepatitis B virus (HBV) and he...
Objective: Screening blood donors for sexually transmitted diseases is becoming increasingly importa...
Abstract Hepatitis is disease of the liver caused by the infectious and non-infectious agents. The a...
Abstract. The prevalence of HCV seropositivity observed in various populations raise the issue of th...
IntroductionEstimation of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficienc...
A second generation test for HCV antibody detection in sera coming from Stip county is used. The per...
Latest estimates indicate that world prevalence of anti-HCV reactivity spans widely from 0.1% in dev...
Introduction Estimation of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficien...
Hepatitis is disease of the liver caused by the infectious and non-infectious agents. The aim of stu...
BACKGROUND: The epidemiology of hepatitis C virus (HCV) infection has been studied in many countries...
Background: In Brazil, it is estimated that between 2.5 and 4.9% of the general population present a...
In 2022, the Lithuanian health authorities decided to pay general practitioners a fee for performing...
It is estimated that approximately 130-170 million people worldwide are infected with hepatitis C vi...
Given the scarcity of epidemiological information on hepatitis C virus (HCV) infection in Northern B...